✦ LIBER ✦

Phase III study (MONET1) of motesanib plus carboplatin/paclitaxel in patients with advanced nonsquamous nonsmall-cell lung cancer (NSCLC): Asian subgroup analysis

✍ Scribed by Kubota, K.; Ichinose, Y.; Scagliotti, G.; Spigel, D.; Kim, J. H.; Shinkai, T.; Takeda, K.; Kim, S.- W.; Hsia, T.- C.; Li, R. K.; Tiangco, B. J.; Yau, S.; Lim, W.- T.; Yao, B.; Hei, Y.- J.; Park, K.

Book ID: 121749641
Publisher: Oxford University Press
Year: 2014
Tongue: English
Weight: 273 KB
Volume: 25
Category: Article
ISSN: 0923-7534
DOI: 10.1093/annonc/mdt552

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

International, Randomized, Placebo-Contr

International, Randomized, Placebo-Controlled, Double-Blind Phase III Study of Motesanib Plus Carboplatin/Paclitaxel in Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer: MONET1

✍ Scagliotti, G. V.; Vynnychenko, I.; Park, K.; Ichinose, Y.; Kubota, K.; Blackhal 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 242 KB

9165 Motesanib or bevacizumab in combina

9165 Motesanib or bevacizumab in combination with paclitaxel and carboplatin in patients with advanced nonsquamous non-small cell lung cancer (NSCLC): interim results from a randomized, open-label, phase 2 study

✍ Blumenschein, G.; Schwartzberg, L.S.; Menon, H.; Mok, T.S.K.; Stephenson, J.J.; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

9120 POSTER Linifanib Plus Carboplatin/P

9120 POSTER Linifanib Plus Carboplatin/Paclitaxel (CP) in Japanese Patients With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) -Phase 1 Preliminary Results

✍ Ohvanaqi, F.; Horai, T.; Nishio, M.; Sekine, I.; Yamamoto, N.; Nakagawa, K.; Oka 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Phase I study of paclitaxel, carboplatin

Phase I study of paclitaxel, carboplatin and UFT in chemo-naive patients with advanced non-small cell lung cancer (NSCLC)

✍ Yasushi Ono; Mitsunori Hino; Yuka Ueda; Ryoko Kamizuru; Masatoshi Omata; Takashi 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 123 KB

A phase I pharmacokinetic study of bexar

A phase I pharmacokinetic study of bexarotene with paclitaxel and carboplatin in patients with advanced non-small cell lung cancer (NSCLC)

✍ Jordi Rodon; Charlotte D. Jacobs; Quincy Chu; Eric K. Rowinsky; Arturo Lopez-Ana 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 277 KB

Phase 2 study of S-1 plus carboplatin in

Phase 2 study of S-1 plus carboplatin in patients with advanced non-small cell lung cancer

✍ Kaira, Kyoichi; Sunaga, Noriaki; Yanagitani, Noriko; Imai, Hisao; Utsugi, Mitsuy 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 158 KB